Medicare Advantage vs Medicare Supplement Call Buying

If you've bought calls in both lanes, you already know they don't behave the same way. Medicare Advantage and Medicare Supplement are both Medicare products, but the call buying side of each runs on different clocks, different price tags, different rules. Treat them like the same animal and you'll burn through budget fast.

I've sat in enough rooms with agencies scaling Medicare call campaigns to know the mistake almost everyone makes early on. They assume a "Medicare call" is a Medicare call. It isn't. The intent behind an MA caller and a Medigap caller is different, the compliance load is different, and the payout math is different. Here's where they actually split.

Why does Medicare Advantage generate more call volume?

Medicare Advantage produces higher call volume mainly because of $0 premium marketing during AEP (October 15 to December 7). That pulls in a wide range of callers, including plenty who are just price shopping. Medigap volume is smaller but steadier across the year.

A $0 premium ad is one of the easiest hooks in insurance marketing. It doesn't require the consumer to understand deductibles, coinsurance, or network rules. It just sounds free. That's why UnitedHealthcare, Humana, Aetna, and the rest pour so much money into AEP television and digital spend, and why call volume for MA spikes so hard between mid-October and early December. Then it spikes again during the Medicare Advantage Open Enrollment Period, January 1 to March 31, when people who picked the wrong plan in the fall get a second shot to switch.

Medigap doesn't have that seasonal cliff. In most states you can apply for a Supplement plan any time of year, so lead flow and call flow stay level across the calendar. That evenness matters if you're an agency trying to keep agents busy in July instead of scrambling for volume for ten weeks and then going quiet.

MA calls come in waves tied to enrollment windows. Medigap calls come in more like a steady drip.

Cost per call: why Medigap costs more

Medigap calls typically run $15 to $50 or more. Medicare Advantage calls usually land between $10 and $35. The gap comes down to underwriting and commission structure, not just demand.

Medicare Supplement buyers tend to be more qualified financially. They're often already on Medicare, thinking seriously about out-of-pocket exposure, and willing to pay a monthly premium for broader access and no network restrictions. That's a more valuable caller to an agent, and the commission math backs it up. MA pays a flat first-year commission, generally $600 to $1,000 depending on the state and carrier. Medigap pays a percentage, usually 15% to 25% of the annual premium, so a higher-premium policy sold to an older or higher-rated applicant can be worth more over time than a single MA enrollment.

This is why you'll see call buyers willing to pay double for a Medigap call versus an MA call from the same zip code. They're not paying for the call. They're paying for the commission tail behind it.

There's a wrinkle a lot of new call buyers miss, though.

The underwriting problem nobody budgets for

Medigap policies are medically underwritten outside a person's initial enrollment window or a Guaranteed Issue event. That means a chunk of the premium-priced Medigap calls you're buying will end in a decline or a rate-up, not a sale. Not so with Medicare Advantage, where guaranteed issue applies more broadly regardless of health status.

I've seen agencies get burned here more than once. They see a $40 Medigap call convert at a lower rate than a $20 MA call and assume the vendor sent junk. Sometimes that's true. But often it's just underwriting doing what underwriting does. A 68-year-old with a recent cardiac event might generate a perfectly legitimate, high-intent call and still get declined or rated up by the carrier. That's not a bad call. That's just how a medically underwritten product works. If you're buying Medigap calls, build your close-rate expectations around this instead of comparing them apples-to-apples with MA numbers.

A high Medigap cost per call buys you a bigger commission ceiling. It also buys you a real chance of underwriting decline that MA calls don't carry.

Compliance: two different rulebooks

Medicare Advantage marketing sits under CMS marketing guidelines on top of standard TCPA requirements. That means documented prior express written consent and strict rules around what can be said, recorded, and disclosed on the call. Medigap calls still fall under TCPA and state insurance regulation, but CMS marketing rules don't apply the same way.

This is a bigger deal than most new call buyers realize. CMS oversight on Medicare Advantage tightened a lot in recent years, particularly around recorded consent, required disclaimers, and "one call for one purpose" style restrictions that limit how a lead can be reused or resold. The Centers for Medicare & Medicaid Services sets these rules, and the National Association of Insurance Commissioners shapes a lot of the state-level standards layered on top, especially for Medigap, since Supplement products are regulated more heavily at the state level than the federal one.

If you're buying MA calls, you need airtight consent documentation and a real audit trail. CMS complaints can shut down a call center's ability to work with a carrier fast. Medigap has real compliance requirements too, don't get me wrong. TCPA violations are still TCPA violations no matter the product. But you're not sitting under the same federal marketing framework that governs MA.

MA calls carry a heavier compliance burden. Medigap carries a lighter, but still real, one.

Timing your buys around the calendar

AEP (October 15 to December 7) is the obvious anchor point for both products, but it's really an MA event more than a Medigap one. That's when you'll see the most competition for MA calls and the steepest bidding. The Medicare Advantage Open Enrollment Period, January 1 to March 31, gives you a second, smaller window for MA switch and disenroll traffic. Special Enrollment Periods triggered by qualifying life events, like a move to a new service area or a loss of employer coverage, create smaller pockets of volume for both products year-round, and savvy buyers keep a standing budget for these instead of only turning the spend on for AEP.

Medigap doesn't need the calendar the same way. You can run a Medigap call program in June with almost the same expectations as October, which is a real advantage if you're trying to keep agent capacity full without the AEP feast-or-famine cycle.

If you're more interested in generating these calls yourself instead of buying them from someone else, that's a whole different skill set. It's the one I wrote about in The Pay Per Call Revolution, which walks through building your own inbound call volume rather than competing for it on the open market.

FAQ

Is Medicare Advantage or Medigap easier to close on a live transfer? MA calls generally close faster since there's no medical underwriting hurdle. Medigap calls can start strong but stall out or get declined once underwriting kicks in, especially outside Guaranteed Issue periods.

Do Medigap calls need CMS compliance too? No, not the CMS marketing guidelines specific to Medicare Advantage and Part D. Medigap is still subject to TCPA and state insurance regulation, but not the same federal CMS framework.

Why do MA leads cost less than Medigap leads if AEP volume is so high? Higher volume brings the price down, but the bigger factor is commission size. Medigap's percentage-based commission on higher premiums justifies a higher cost per call for buyers.

Can I buy Medigap calls year-round or only during AEP? Year-round, in most states. Medigap enrollment isn't restricted to AEP like Medicare Advantage, so volume and buying opportunities spread more evenly across the calendar.

What's the biggest compliance mistake call buyers make with MA calls? Weak or missing documentation of prior express written consent. CMS and TCPA enforcement both focus heavily on this, and it's the first thing checked when a complaint comes in.